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Aging can be defined as progressive functional de-
cline and increasing mortality over time. Here, we re-
view evidence linking aging to nuclear DNA lesions:
DNA damage accumulates with age, and DNA repair
defects can cause phenotypes resembling premature
aging. We discuss how cellular DNA damage re-
sponses may contribute to manifestations of aging.
We review Sir2, a factor linking genomic stability, me-
tabolism, and aging. We conclude with a general dis-
cussion of the role of mutant mice in aging research
and avenues for future investigation.
Introduction
Although aging is nearly universally conserved among
eukaryotic organisms, the molecular mechanisms un-
derlying aging are only beginning to be elucidated. A
useful conceptual framework for considering the prob-
lem of aging is the Disposable Soma model (Kirkwood
and Holliday, 1979). This model proposes that organ-
isms only invest enough energy into maintenance of the
soma to survive long enough to reproduce. Aging oc-
curs at least in part as a consequence of this imperfect
maintenance, rather than as a genetically programmed
process. Although aging may involve damage to vari-
ous cellular constituents, the imperfect maintenance of
nuclear DNA likely represents a critical contributor to
aging. Unless precisely repaired, nuclear DNA damage
can lead to mutation and/or other deleterious cellular
and organismal consequences. Damage to both nuclear
DNA, which encodes the vast majority of cellular RNA
and proteins, and mitochondrial DNA have been pro-
posed to contribute to aging (Karanjawala and Lieber,
2004). The reader is referred to the review by Balaban
et al. in this issue of Cell concerning the potential role
of mitochondrial DNA damage in aging (Balaban et al.,
2005). Nuclear DNA is an attractive target for aging-
related changes since it must last the lifetime of the
cell, unlike other cellular constituents, which can be re-
placed. In addition, the nuclear genome is present at
only two to four copies per cell, rendering it potentially
very vulnerable to lesions; by contrast, the mito-
chondrial genome is present at several thousand cop-*Correspondence: alt@enders.tch.harvard.eduies per cell. Many mutants with phenotypes that resem-
ble premature aging possess defects in nuclear DNA
repair. Therefore, we focus on the role of nuclear DNA
damage in mammalian aging, emphasizing recent work
in mouse models.
DNA Damage, Reactive Oxygen Species, and Aging
A large body of evidence argues that DNA damage and
mutations accumulate with age in mammals (Vijg,
2000). Cells harboring mutations at defined loci have
been shown to increase with age in humans and mice.
Cytogenetically visible lesions such as translocations,
insertions, dicentrics, and acentric fragments also ac-
cumulate in aging mammalian cells. Mice with inte-
grated reporter arrays have allowed estimates of the
age-related occurrence of both point mutations and
larger genomic rearrangements. Such analyses have
revealed considerable variation in mutation spectra be-
tween different tissues. These differences likely reflect
functional characteristics of those tissues, such as mi-
totic rate, transcriptional activity, metabolism, and the
action of specific DNA repair systems.
Reactive Oxygen Species: An Important Source
of Age-Related DNA Damage
There are many sources of DNA damage. In addition to
external sources, such as ionizing radiation and geno-
toxic drugs, there are also cell-intrinsic sources, such
as replication errors, spontaneous chemical changes to
the DNA, programmed double-strand breaks (DSBs) (in
lymphocyte development), and DNA damaging agents
that are normally present in cells. The latter category
includes reactive oxygen species (ROS), such as super-
oxide anion, hydroxyl radical, hydrogen peroxide, nitric
oxide, and others. Major sources of cellular ROS pro-
duction are the mitochondria, peroxisomes, cytochrome
p450 enzymes, and the antimicrobial oxidative burst of
phagocytic cells. ROS can cause lipid peroxidation,
protein damage, and several types of DNA lesions: sin-
gle- and double-strand breaks, adducts, and cross-
links. The situation in which ROS exceed cellular anti-
oxidant defenses is termed oxidative stress. As normal
byproducts of metabolism, ROS are a potential source
of chronic, persistent DNA damage in all cells and may
contribute to aging (Sohal and Weindruch, 1996). The
ROS theory of aging is discussed in depth in this issue
of Cell by Balaban et al. (2005). In brief, longer-lived
species generally show higher cellular oxidative stress
resistance and lower levels of mitochondrial ROS pro-
duction than shorter-lived species. Caloric restriction,
an intervention that extends life span in many organ-
isms, likely decreases ROS production (Barja, 2004). In
model organisms, many mutations that promote lon-
gevity concomitantly increase oxidative stress resis-
tance (Finkel and Holbrook, 2000). In addition, levels of
8-oxoguanine (oxo8dG), a major product of oxidative
damage to DNA, accumulate with age (Hamilton et al.,
2001).
The potential importance of oxidative damage to
DNA in age-related dysfunction is highlighted by a re-
Cell
498cent study of postmortem human brain tissue (Lu et al., p
c2004), which found that many nuclear genes involved
in critical neural functions show reduced expression af- a
pter age 40, concomitant with elevated levels of oxo8dG
and DNA damage in their promoters. However, the high c
Rlevels of oxidative DNA damage found by these investi-
gators is at odds with other much lower estimates of a
Ithe amount of oxidatively damaged DNA in cells (Hamil-
ton et al., 2001). This highlights the difficulty of accu- c
crately measuring ROS and oxidative damage experi-
mentally. Additional unresolved issues concerning the t
cROS theory of aging exist that will require clarification.
If ROS are indeed an important source of aging-associ- m
wated damage, it is currently unclear whether nuclear or
mitochondrial DNA is the most relevant functional t
otarget (Barja and Herrero, 2000; Hamilton et al., 2001).
Among long-lived mutants, the correlation with oxida- l
ftive stress resistance is a frequent but not universal
one: in some mutants, longevity occurs despite un- a
ichanged resistance to ROS or other forms of stress.
Additionally, mice heterozygous for a mutation in the p
imitochondrial enzyme that processes superoxide, Sod2,
live out a normal lifespan, despite accumulating higher o
dlevels of nuclear and mitochondrial 8oxodG with age
(Van Remmen et al., 2003). Thus, while several lines of r
tevidence argue for important role for ROS in aging,
many questions remain regarding this hypothesis. In c
ethis regard, it is possible that additional mutations may
be required to fully unveil potential effects of ROS f
g(see below).
o
oCellular Senescence: A Link between Cellular
(Damage and Aging?
aROS and many other DNA-damaging agents can cause
ccells to enter a state of irreversible cell cycle arrest ac-
(companied by characteristic morphologic and func-
tional alterations, termed senescence (Ben-Porath and
pWeinberg, 2004). The induction of senescence depends
ron pathways involving the p53 and Rb proteins (Figure
e1). Cellular senescence has been best characterized in
2cultures of human fibroblasts and mouse embryo fibro-
blasts (MEFs), which cease expanding after repeated tFigure 1. Multiple Pathways to Senescence
These pathways are employed in a cell- and
organism-specific fashion. In MEFs, activa-
tion of p19ARF leads to stabilization of p53.
In certain human cell types (e.g., fibroblasts
and keratinocytes), telomere attrition can ac-
tivate p53 via the ATM and (potentially) ATR
kinases. Senescence can also be triggered
in human cells via p16 expression (Itahana et
al., 2004).
Activated p53 induces senescence via a
complex gene expression program that in-
cludes induction of p21. The role of Rb in
senescence involves repression of E2F target
genes as well as alterations in chromatin
structure. Senescent cells may contribute to
aging via depletion of stem cell pools and/
or elaboration of factors that interfere with
tissue function. Factors elaborated by se-
nescent cells may also stimulate the growth
of epithelial tumors (Krtolica and Campisi,
2002).assage in culture, a process termed replicative senes-
ence. Replicative senescence has been employed as
cellular model for aging; many mutations in DNA re-
air genes that cause premature aging phenotypes also
onfer premature replicative senescence (Table 1).
eplicative Senescence Differs between Human
nd Mouse Cells
n many primary human cell lines, replicative senes-
ence occurs secondary to attrition of the ends of the
hromosomes, the telomeres, in a process termed “in-
rinsic senescence” (Itahana et al., 2004). In mammalian
ells, the ends of the chromosomes consist of a ter-
inal 3# single-stranded tail, the G strand overhang,
hich is buried into adjacent double-stranded repeti-
ive telomeric DNA, forming a protective “t loop” higher-
rder structure (de Lange, 2002). This t loop is stabi-
ized by a “D loop,” or displacement loop: the region
ormed between the invading end of the telomere into
djacent double-stranded DNA. The G strand overhang
s the substrate for the enzyme telomerase, which em-
loys an RNA template, Terc, to extend telomeres dur-
ng S phase, thereby countering the natural shortening
f telomeres that would otherwise occur with each cell
ivision. Telomerase access to its substrate is, in turn,
egulated by telomeric proteins, which also modulate
he conformational changes required for telomere repli-
ation and subsequent reestablishment of a protective
nd structure. In many types of human cells, including
ibroblasts, telomeres shorten with each successive
eneration. Critically short telomeres trigger the onset
f senescence through a process that may involve loss
f the t loop structure and/or loss of protective proteins
referred to as “uncapping”). Such uncapped telomeres
re then recognized by the cell cycle checkpoint ma-
hinery as DNA damage, leading to cell cycle arrest
Ben-Porath and Weinberg, 2004).
In contrast to primary human fibroblasts, which ex-
ress very low levels of telomerase activity, MEFs de-
ived from M. musculus possess long telomeres and
asily detectable telomerase activity (Itahana et al.,
004). Thus, MEFs ordinarily do not senesce due to
elomeric attrition. Instead, senescence of wild-type
Review
499Table 1. Features of Selected Models of Premature Aging in the Mouse
Accelerated
Increased Rate of Fibroblast
Mutant Cellular Process Affected Tissues Affected Cancer? Senescence? Citations
Atm DSB signaling/repair Cerebellum, Gonad, Yes Yes (Ito et al., 2004;
Hematopoietic Shiloh and Kastan,
organs, Thymus 2001)
Bub1bH/H Spindle assembly Bone, Lens, Skin, No Yes (Baker et al., 2004)
checkpoint Gonad
BRCA111/11/ DSB repair, other Bone, Eye, Heart, Yes Yes (Cao et al., 2003b)
p53+/− Intestine, Liver,
Lymphocytic
hyperplasia, Testes
+others
DNA-PKcs NHEJ, other Bone, Intestine Yes No (Espejel et al., 2004b)
Ercc1, XPF Nucleotide excision repair, Liver (Ercc1, XPF) + No Yes (Ercc1) (McWhir et al., 1993;
crosslink repair, other Brain, Kidney, Skin, Tian et al., 2004;
Spleen—Ercc1 Weeda et al., 1997)
Ku80 NHEJ, other Bone, Liver, Skin No Yes (Vogel et al., 1999)
Dysfunctional p53 DNA damage response Bone, Hair, Lymphoid No ND (Tyner et al., 2002)
(p53m/+) tissue, Skin
Dysfunctional p53 DNA damage response Bone, Testes No Yes (Maier et al., 2004)
(p44 Tg)
PASG/Lsh DNA methylation Bone, Hair, Kidney, No Yes (Sun et al., 2004)
Skin, Thymus
PolgA Mitochondrial DNA Bone, Hair, Heart, No ND (Trifunovic et al.,
polymerase Hematopoietic 2004)
organs, Skin,
Testes
Rad50S/S DSB repair Hematopoietic Yes No (Bender et al., 2002)
organs, Testes
Terc Telomere maintenance Hematopoietic Conflicting results Yes (Espejel et al., 2004a;
organs, Hair, Heart, Lee et al., 1998)
Intestine,
Myometrium, Skin,
Testes
Terc/Atm Telomere maintenance/ Bone, Brain, Hair, No Yes (Wong et al., 2003)
DSB signaling/repair Hematopoietic
organs, Intestine
Terc/DNA-PKcs Telomere maintenance/ Intestine, Various No ND (Espejel et al., 2004a)
NHEJ, other
Terc/Parp-1 Telomere maintenance/ Various No ND (Espejel et al., 2004a)
DNA repair
Terc/Ku80 Telomere maintenance/ Intestine, Various No ND (Espejel et al., 2004a)
NHEJ, other
Terc/Wrn Telomere maintenance/ Bone, Endocrine, Yes Yes (Chang et al., 2004)
DNA repair Gonad, Hair,
Intestine, Lens,
Skin, Spleen
Terc/Wrn/Blm Telomere maintenance/ Bone, Endocrine, Yes Yes (Du et al., 2004)
DNA repair Gonad, Hair,
Intestine
TopIIIbeta Topoisomerase Kidney, Lymphocytic No ND (Kwan et al., 2003)
infiltrates,
Pancreatic islets,
Skin, Testes
Wrn DNA repair None No Yes (Lebel and Leder,
1998; Lombard et
al., 2000)
XPA/CSB NER, transcription Cerebellum No ND (Murai et al., 2001)
XpdTTD NER, transcription Bone, Hair, Ovary, Yes ND (de Boer et al., 2002)
Skin
XpdTTD/XPA NER, transcription Bone, Hair, Skin No ND (de Boer et al., 2002)MEFs occurs primarily in response to oxidative DNA
damage incurred during cell culture (Parrinello et al.,
2003) in a process termed “extrinsic senescence” (Ita-
hana et al., 2004). These differences between human
and mouse cells with respect to senescence are not asgreat as they may seem. Terc deficiency in mice leads
to progressive telomere attrition in successive mouse
generations and rapid senescence in embryonic fibro-
blasts derived from late-generation animals (Espejel
and Blasco, 2002). Replicative life span of human cells
Cell
500is altered by culture under different oxygen tensions, T
and telomere shortening in these cells is itself ac- B
celerated by elevated levels of oxidative stress. It is
Hnow clear that senescence can be induced by a variety
Aof different types of cellular injury (Figure 1).
ACellular Senescence and Aging
HWhat is the relationship between cellular senescence
E
and aging? The evidence that cellular senescence ac- L
tually plays a role in aging is correlative: senescent cells L
Maccumulate in vivo in mammals with increasing age and
Mat sites of pathology (Itahana et al., 2004), and many
Omouse and human models of premature aging are ac-
Pcompanied by premature cellular senescence in vitro
P
(Table 1). Of note, late-generation Terc-deficient mice S
show some signs of accelerated aging (Lee et al., 1998; T
URudolph et al., 1999). Two general models have been
proposed to explain how cellular senescence may con- L
tribute to aging (Krtolica and Campisi, 2002; Pelicci,
K
2004). First, senescence of progenitor or stem cells L
themselves could impair tissue renewal. In this regard, L
the Polycomb group repressor Bmi1 appears to control M
Plevels of hematopoietic stem cells via negatively regu-
Slating the induction of senescence specifically in these
Gstem cells. Second, senescent cells secrete proteases
and other factors that may disrupt tissue function. In H
this regard, senescence has a complex relationship O
Swith neoplasia. Senescence has been postulated to oc-
Rcur as a tumor suppressor mechanism, whereby cells
that have undergone a genotoxic insult and therefore B
possess the potential for neoplastic transformation en- D
ter a state in which they are incapable of dividing (Krtol- D
Mica and Campisi, 2002). However, senescent stromal
Pcells can actually promote the growth of epithelial can-
cers, malignancies that occur with increased incidence N
in the elderly. Senescence has been offered as an ex- H
ample of “antagonistic pleiotropy,” a process that is N
beneficial in young organisms but deleterious later in R
Wlife: senescence suppresses cancer by preventing po-
tentially tumorigenic cells from dividing but may poten- O
tially contribute to organ dysfunction in the aged A
through a variety of mechanisms, perhaps even con- F
tributing to neoplasia in this setting (Krtolica and Cam- F
Hpisi, 2002). However, a causal relationship between cel-
Tlular senescence and organismal aging has yet to be
proved.
DNA Repair and Aging
p
The accurate maintenance of nuclear DNA is critical to
F
cellular and organismal function, and therefore, numer-
t
ous DNA repair systems have evolved. There is some
o
evidence that the intrinsic fidelity and activity of such
s
systems in different species may influence the rate of
t
age-associated functional decline (Hart and Setlow,
v
1974), although such studies need to be performed with
modern methodology. As outlined below, the efficiency
of cellular DNA repair machinery itself may decline with T
Dage. Many different types of DNA lesions exist. DNA
DSBs are repaired via the nonhomologous end-joining U
p(NHEJ) and homologous recombination (HR) pathways,
whereas lesions on a single strand of DNA are repaired c
svia base excision repair (BER) and nucleotide excision
repair (NER) (and its subpathways). In mice and hu- f
tmans, mutations in certain DNA repair genes lead tohenotypes that, in some respects, caricature aging.
or reference, the features of aging as it occurs in wild-
ype mice are enumerated in Table 2, and the features
f mouse DNA repair/metabolism mutants showing
ome features of aging are listed in Table 1. We now
urn to discussing specific gene defects and their rele-
ance to aging.
he ATM-p53 Axis: A Link between the DNA
amage Response and Aging?
nrepaired or improperly repaired DSBs have serious
otential consequences for the cell: cell death, senes-
ence, dysregulation of cellular functions, genomic in-
tability, and, in higher organisms, oncogenic trans-
ormation. The initial step in DSB repair is detection of
he lesion, and this step involves the ataxia-telangiecta-able 2. Common Pathologic Features of Aging in Mice (after
ronson and Lipman [1991]; Cao et al. [2003a])
yperplasia/Neoplasia
drenal hyperplasia
ngiosarcoma
arderian gland adenoma
ndometrial hyperplasia
ung adenoma
ymphoma
ammary gland adenocarcinoma
ast cell tumor
varian cystadenoma
araovarian cyst
ituitary adenoma
arcoma
hyroid follicular cell hyperplasia
terine leiomyoma/leiomyosarcoma
eukocytic Infiltrates
idney
iver
ung
esentery/omentum
erineurium
alivary gland
enitourinary system
ydronephrosis
varian/testicular atrophy
eminal vesicle dilation
enal tubular dilation
one
ecreased cancellous bone
egenerative joint disease
olar teeth periodontitis
roliferations in the head/spine
eurological
ydrocephalus
euronal lipofuscinosis
adiculopathy
hite matter gliosis
ther
myloidosis
atty change of the liver
ocal myocardial degeneration
epatocyte polyploidization
hymic involution
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501sia mutated (ATM) kinase, other related phosphatidyl-
inositol 3-kinase-like kinases (PIKKs), and other pro-
teins (Figure 2; Bassing and Alt, 2004). Activated ATM
phosphorylates numerous proteins involved in the G1/S,
intra-S, and G2/M checkpoint responses and addition-
ally phosphorylates factors involved in DNA repair
(Bassing and Alt, 2004).
An important target of ATM is the p53 protein, which
plays a role in the cellular response to numerous geno-
toxic insults including DSBs. Phosphorylation of p53 by
ATM and kinases downstream of ATM is a major mech-
anism leading to upregulation of p53 levels and activity,
although p53 also can be activated via ATM-indepen-
dent mechanisms. Activated p53 stimulates or represses
transcription of many target genes and coordinates
checkpoint, senescence, and apoptosis pathways in
response to DSBs and other signals. In this regard, p53,
through modulation of various downstream targets,
triggers arrest/senescence or apoptosis (Meek, 2004).
The exact factors that determine the differential out-
comes of this complex program are not yet completely
elucidated but vary with the cell type, as well as the
kind, intensity, and duration of the damage.
ATM and Aging
Perturbations in ATM function can lead to symptoms of
accelerated aging. Patients with mutations in the ATM
gene suffer from Ataxia-Telangiectasia (AT), a condition
characterized by a prematurely aged (progeroid) ap-
pearance, immunodeficiency, cerebellar degeneration,
and cancer (Shiloh and Kastan, 2001). ATM deficiency
in mice recapitulates many of these phenotypes, al-
though the progeroid features of the mouse models are
less prominent than in the human disease. Given the
many targets of ATM, it is difficult to trace the progeroid
appearance of AT patients to a specific function of thisFigure 2. A Highly Simplified View of the DNA Damage Response
See text for details.protein although several possible mechanisms are con-
ceivable (see below). In this context, the phenotype of
ATM-deficient cells may be relevant. In particular, such
cells manifest sensitivity to DSB-inducing agents and
have marked genomic instability; they also grow poorly
and senesce prematurely in culture (Barzilai et al.,
2002).
Genomic instability or DNA repair defects of ATM de-
ficiency could contribute to the aging-like features of
this disorder (see below). In this context, the premature
cellular senescence phenotype of ATM deficiency is
rescued by p53 deficiency (Xu et al., 1998), suggesting
a role for ATM-independent, p53-dependent check-
point responses. By extension, such responses also
might contribute to premature-aging phenotypes asso-
ciated with ATM deficiency. Another potential function
for ATM in suppressing progeroid phenotypes may be
related to reported ATM functions in regulating intracel-
lular ROS levels and sensitivity to these molecules (Bar-
zilai et al., 2002; Ito et al., 2004). Persistently elevated
ROS levels in AT cells might cause chronic damage to
DNA and other cellular macromolecules. However,
given the lack of an AT-like phenotype of the Sod2+/−
mouse, progeroid features of ATM deficiency likely re-
flect more than increased ROS levels. One possibility
would be elevated ROS levels in conjunction with loss
of another ATM function, such as ability to respond to
ROS-induced DNA damage. Finally, ATM plays an im-
portant role in telomere maintenance; AT cells show
shortened telomeres and an increased incidence of te-
lomeric fusions (Pandita, 2002). Moreover, mice lacking
both ATM and Terc have higher levels of telomeric dys-
function than generation-matched Terc-deficient mu-
tants, as well as proliferative defects in multiple tissues,
decreased survival, and clinical evidence of premature
aging (Wong et al., 2003). Thus, human AT patients may
show aging-like effects, at least in part, as a conse-
quence of telomeric dysfunction, an effect that ordinar-
ily may be masked in the mouse due to the long telo-
meres of this organism.
The phenotypes of ATM deficiency are influenced by
environmental conditions. In the ATM-deficient mouse,
the onset of T cell lymphoma can be delayed by treat-
ment with an antioxidant, suggesting that dietary factors
impact on the expression of this condition (Schubert et
al., 2004). Neurological dysfunction in this model can
similarly be ameliorated via antioxidant treatment (Browne
et al., 2004). Additionally, the frequency of thymic lym-
phoma varies among different strains of ATM-deficient
mice, a finding that might reflect different background
mutations and/or housing conditions and the types of
pathogens present (Petiniot et al., 2002). These obser-
vations raise the possibility that other aspects of the
ATM-deficient phenotype, including the premature
aging observed in human patients, may be influenced
by environment. This is a theme that we will return to
in our discussion of other premature aging models.
p53 and Aging
Various lines of evidence suggest that p53 plays op-
posing roles in the aging process. While p53 sup-
presses the onset of malignancy and thereby extends
life span, at the same time it promotes cellular senes-
cence and apoptosis in response to DNA damage, po-
tentially contributing to the clinical changes of aging.
Cell
502Thus, p53 function may display antagonistic pleiotropy K
t(Campisi, 2002). The role of p53 in aging cannot be di-
trectly tested using p53-deficient mice, as such animals
Pinvariably die of malignancy before age-related changes
abecome manifest. However, two mouse strains that ex-
tpress C-terminal p53 fragments along with full-length p53
ehave been reported to show accelerated aging pheno-
Ktypes and a lower incidence of malignancy (Maier et al.,
t2004; Tyner et al., 2002). It has been proposed that
othese truncated p53 proteins exert their effects by
Dmodifying the activity of endogenous wild-type p53
Dprotein. Only nonphysiologic activation of p53 leads to
fprogeria, as mice expressing extra copies of wild-type
cp53 under the control of its own promoter do not show
Isigns of premature aging (Garcia-Cao et al., 2002).
cFurther arguing for a role for p53 in promoting aging,
ia null mutation in a gene functioning downstream of
p53 in the induction of apoptosis, p66Shc, confers oxi-
adative stress resistance and extends mouse life span
s(Migliaccio et al., 1999). The p66Shc protein shortens
nmurine life span via at least two mechanisms: it in-
rcreases constitutive intracellular ROS levels, and it pro-
nmotes cell death in response to oxidative stress. It is
iunclear how p66shc evolved to play such a role in the
tcell, since the shorter isoforms of this protein, p52 and
Ap46, fulfill an entirely dissimilar cellular function, trans-
cducing signals from tyrosine kinases to ras.
i
m
A Putative Role for NHEJ in Suppressing Aging a
NHEJ in DSB Repair and Telomere Maintenance a
We now turn from a discussion of factors upstream of b
DNA repair to a consideration of repair pathways them- K
selves and their involvement in aging. NHEJ is one of t
the two major DSB repair pathways in mammalian cells f
(Bassing and Alt, 2004). NHEJ is mediated by at least a
csix core factors (Figure 3). Four of these proteins (Ku80,Figure 3. NHEJ at General DSBs
Factors associated with progeroid mutant
phenotypes (Ku80 and DNA-PKcs) are
shown in red. See text for details.u70, Ligase IV, and XRCC4) are conserved from yeast
o mammals; they are indispensable for all NHEJ reac-
ions. In contrast, the other two NHEJ factors, DNA-
Kcs (DNA-dependent protein kinase catalytic subunit)
nd Artemis, have evolved more recently and are
hought to be required for joining the subset of DNA
nds that require processing prior to ligation. Ku70 and
u80 bind as a heterodimer to DSBs, where they are
hought to serve a protective function and to enlist
ther factors. In this regard, Ku70 and Ku80 recruit
NA-PKcs, and together the three proteins form the
NA-PK holoenzyme. DNA-PK activates Artemis, which
unctions as an endonuclease to process ends that
annot be directly rejoined. Finally, XRCC4 and Ligase
V, which are likely recruited by Ku, function together to
atalyze end ligation itself. NHEJ often occurs concom-
tant with loss of a few nucleotides at the site of joining.
NHEJ plays a critical role in general DNA DSB repair
nd, correspondingly, in the maintenance of genomic
tability. In addition, NHEJ plays a role in repairing ge-
etically programmed DSBs in the context of antigen
eceptor variable region gene assembly (V(D)J recombi-
ation) in developing lymphocytes. Mice with targeted
nactivating mutations in NHEJ genes display pheno-
ypes that reflect loss of these functions (Ferguson and
lt, 2001). All NHEJ-deficient mice suffer from severe
ombined immunodeficiency as a consequence of an
nability to productively rejoin broken V(D)J gene seg-
ents in developing B and T cells. NHEJ deficiency is
lso associated with ionizing radiation-sensitivity and
n elevated incidence of spontaneous genomic insta-
ility. MEFs deficient for XRCC4, Ligase IV, Ku70, or
u80 (but not DNA-PKcs or Artemis) senesce prema-
urely in culture, and mice deficient for these four
actors are very small and show widespread neuronal
poptosis during embryogenesis. Premature senes-
ence and neuronal apoptosis, but not small size, are
Review
503relieved by p53 deficiency. Thus, the former pheno-
types occur as a response to, rather than as a direct
consequence of, unrepaired DSBs (Ferguson and Alt,
2001). Mice deficient in NHEJ and p53 invariably suc-
cumb to pro-B cell lymphomas as a consequence of
aberrant repair of V(D)J recombination-associated
DSBs in developing B cells, leading to oncogenic trans-
locations (Bassing and Alt, 2004).
In addition to their roles in DSB repair, at least three
core NHEJ factors, namely Ku70, Ku80, and DNA-PKcs,
localize to telomeres (d'Adda di Fagagna et al., 2001).
Deficiency for any of these, as well as for Artemis
(Rooney et al., 2003), is associated with an increased
frequency of end-to-end chromosomal fusions in MEFs,
suggesting a role for these proteins in chromosomal end
capping. There is conflicting data on whether NHEJ
factors protect against telomere shortening. NHEJ also
promotes telomeric fusions in some circumstances. In-
creased telomere end-to-end fusions are observed in the
setting of the telomeric attrition associated with Terc defi-
ciency or inhibition of TRF2, a protein thought to function
in end capping, and these end-to-end fusions are elimi-
nated in NHEJ-deficient backgrounds (Espejel et al.,
2002a, 2002b; Smogorzewska et al., 2002). Thus, by li-
gating uncapped telomeres, NHEJ may actually pro-
mote genomic instability. Aside from roles in the NHEJ
reaction and in telomere maintenance, Ku70, Ku80,
DNA-PKcs, and Artemis have other known or sus-
pected cellular functions, including DSB or checkpoint
signaling, whereas XRCC4 and Ligase IV appear to
function only in end-ligation during NHEJ. In summary,
NHEJ plays crucial roles in general and site-specific
DSB repair, in telomere maintenance, and in mainte-
nance of genomic stability.
A Potential Relationship between Ku80 Deficiency,
DNA-PKcs Deficiency, and Aging
NHEJ has been proposed to play a causative role in the
aging process. DSBs are frequent events in mammalian
somatic cells, where they are also very commonly re-
paired by NHEJ. In addition, genetic studies support
the notion that NHEJ plays an important role in the re-
pair of ROS-induced DNA lesions (Karanjawala and
Lieber, 2004). Since NHEJ can delete a few nucleotides
at sites of DSB repair, this process theoretically could
lead to accumulation of mutations and contribute to
cellular decline and aging (Karanjawala and Lieber,
2004). Moreover, in the absence of NHEJ, DSBs often
are repaired concomitant with large deletions and/or
translocations; thus, absent or even decreased levels
of NHEJ also might contribute to accelerated aging.
The observation that phenotypes resembling ac-
celerated aging have been described in one strain each
of Ku80- and DNA-PKcs-deficient mice potentially sup-
ports this model. Thus, a line of Ku80-deficient mice
prematurely exhibits age-specific changes including
osteopenia, atrophic skin, liver lesions, and shortened
life span (Vogel et al., 1999). Likewise, a strain of DNA-
PKcs-deficient mice recently has been noted to exhibit
age-related pathologies, with osteopenia, intestinal at-
rophy, thymic lymphoma, and reduced longevity (Es-
pejel et al., 2004b). There are several potential explana-
tions to account for how NHEJ deficiency could cause
aging-like phenotypes. As described above, spontane-
ous DSBs in Ku80- or DNA-PKcs-deficient animalscould directly impair cellular function by promoting
DNA deletions. In this context, Ku80-deficient mice are
found to have a low rate of mutations at a marker locus
(Rockwood et al., 2003); such an assay might not de-
tect large deletions or rearrangements, however. Alter-
natively, unrepaired DSBs could trigger elevated levels
of cellular senescence and apoptosis. In this regard,
p53-dependent responses are critical in mediating the
premature senescence and neuronal apoptosis pheno-
types of certain NHEJ mutants (Ferguson and Alt,
2001).
Despite the phenotypes of the Ku80- and DNA-PKcs-
deficient mice, several observations suggest that any
potential roles for NHEJ in suppressing aging might be
more complicated. Ku70- and Artemis-deficient mice
thus far have not been reported to show premature
aging phenotypes. If Ku70-deficient mice actually lack
an aging phenotype, the apparent Ku80-deficient pro-
geroid phenotype must be rationalized in the context
of the finding that targeted ablation of Ku70 results in
dramatically reduced Ku80 levels (Gu et al., 1997). In
addition, aging-related phenotypes thus far have not
been reported in several other independently generated
DNA-PKcs mutant mouse strains. Ligase IV- and XRCC4-
deficient mice show embryonic lethality due to wide-
spread neuronal apoptosis, precluding aging analyses.
However, the lack of a consistent aging-like phenotype
in other lines of long-lived Ku-, DNA-PKcs-, or Artemis-
deficient mice is difficult to explain if NHEJ plays a gen-
eral role in delaying manifestations of aging (Karanjawala
and Lieber, 2004). In this regard, it is conceivable that
some aging-related phenotypes might have been
missed due to lack of thorough examination of other
strains of NHEJ-deficient mice.
Background mutations in various strains of NHEJ-
deficient mice, either exacerbating or suppressing the
progeroid manifestations of NHEJ deficiencies, might
contribute to the apparently discrepant phenotypes of
different lines. This possibility, which is relevant to any
gene deficiency/aging model, warrants further exami-
nation and is discussed in other contexts below. Also,
given that both the Ku80- and DNA-PKcs-deficient
mice show evidence of ongoing inflammation, poten-
tially indicative of infection, it is conceivable that some
aging-like phenotypes might occur directly due to the
effects of chronic infection in the setting of immunode-
ficiency, rather than due to impaired DNA repair. Os-
teopenia, for example, could result from elevated gluco-
corticoid levels induced by chronic physiologic stress
from infection or malnutrition associated with intestinal
atrophy. The degenerative changes in afflicted strains
of DNA-PKcs- and Ku80-deficient mice affect only a
limited subset of organs. Therefore, either these NHEJ
factors are only involved in suppressing aging-related
changes in certain tissues or these degenerative changes
occur for reasons distinct from those that contribute to
aging in wild-type animals. Of note, degenerative changes
in these models occur in both highly proliferative (intes-
tine and skin) and relatively less proliferative (bone and
liver) tissues, apparently sparing many other tissues of
both types. These observations argue against a simple
relationship between mitotic status and dependence on
NHEJ in the suppression of aging.
In addition to the above considerations, other models
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fpostulated. It is notable that efficiency of DSB repair
gmay decline with age in budding yeast (McMurray and
pGottschling, 2003) and in mammalian tissues (Sedelni-
pkova et al., 2004; Singh et al., 2001), as well as in senes-
tcent mammalian cells (Seluanov et al., 2004). Theoreti-
vcally, such an age-related decline in DSB repair might
rcontribute to increased mutations and genomic re-
darrangements preferentially near the end of life, al-
mthough such a decline has not been rigorously proven.
(Also, loss of other functions of DNA-PKcs or Ku80,
asuch as telomere end capping and/or DNA damage sig-
analing, could contribute to aging phenotypes. In this
Rcontext, targeted inactivation of either Ku80 or DNA-
wPKcs, but not in Ligase IV or XRCC4, demonstrates
osynthetic lethality with ATM deficiency. These observa-
qtions argue for overlapping functions between Ku/DNA-
tPKcs and ATM that do not involve classical NHEJ, per-
shaps related to telomere maintenance (Sekiguchi et al.,
t2001). Moreover, Ku80/Terc and DNA-PKcs/Terc double
adeficient mice show exacerbation of intestinal atrophy
tand other aging-like phenotypes of Terc deficiency (Es-
gpejel et al., 2004a). Late generation Terc-deficient mice
Phave an uncharacterized DSB repair defect (Wong et
Bal., 2000); loss of NHEJ in the context of dysfunctional
Ttelomeres would be predicted to further compromise
cDSB repair. In this regard, cells deficient in Ligase IV
cand ATM or Terc and ATM show high levels of genomic
winstability and very rapid senescence (Sekiguchi et al.,
l2001; Wong et al., 2003), pointing to synergies between
mDSB repair, DNA damage signaling, and telomere main-
etenance in genomic maintenance and overall cellular vi-
2ability.
tIn summary, there are many potential roles for NHEJ
tin preventing premature aging-like phenotypes, such as
(those observed in Ku80- and DNA-PKcs-deficient
Smice. Current findings suggest, however, that aging
fphenotypes likely do not result from a failure of DSB
drepair alone but instead from a loss of other functions
nor combinations of functions of these proteins, perhaps
ain concert with environmental factors, such as housing
mconditions and/or infection and/or background muta-
Ttions. Such complexities also may likely apply to other
r
DNA repair proteins implicated in the suppression of
f
aging as well, since, as we shall see, many of these
f
proteins play roles in other cellular processes besides E
DNA repair and, as with NHEJ, only a subset of mutants v
in any given DNA repair pathway show aging-related d
phenotypes. d
m
Potential Roles for Rad50 and BRCA1 c
in HR and Aging v
HR in DSB Repair t
Two factors with roles in HR, Rad50 and BRCA1 (breast 2
cancer susceptibility gene-1), appear linked to aging- p
like phenotypes in mouse models. HR is the other major B
pathway of DSB repair in mammalian cells. Unlike S
NHEJ, HR uses the sister or (in some cases) the homol- D
ogous chromosome as a template to repair the broken t
chromosome. p
Whereas recent data indicate that NHEJ functions in e
DSB repair throughout the cell cycle, HR is largely re- (
estricted to late S/G2 (Couedel et al., 2004; Mills et al.,004; Rothkamm et al., 2003; Takata et al., 1998). The
irst step in HR is processing of DSBs by a nuclease to
enerate 3# ssDNA tails, which are coated with RPA
rotein (Figure 4). The MRN complex, composed of the
roteins Mre11, Rad50, and Nbs1, is a candidate for
his nuclease, although other nucleases are likely in-
olved as well. The MRN complex plays multiple other
oles in DSB repair: it functions both upstream and
ownstream of ATM and has been proposed to pro-
ote sister chromatid association and recombination
Stracker et al., 2004). The Rad51 protein, assisted by
number of factors including Rad52, Rad54, BRCA2,
nd the Rad51 paralogs (XRCC2, XRCC3, Rad51B,
ad51C, and Rad51D), forms a nucleoprotein complex
ith the DNA and directs the 3# ssDNA tails to search
ut, invade, and pair with undamaged homologous se-
uences. DNA polymerases then carry out repair using
he intact DNA as a template. The processes of DNA
trand exchange and extension generate Holliday junc-
ions (HJs), structures in which two dsDNA duplexes
re intertwined. In mammalian DSB repair, HJs are
hought to be resolved primarily via disengagement and
ap repair rather than cleavage of the HJ (Valerie and
ovirk, 2003).
RCA1 in HR and Other Cellular Processes
he biology of the BRCA1 protein has proven to be very
omplex; BRCA1 plays roles in multiple fundamental
ellular processes. Biochemically, BRCA1, together
ith its partner protein BARD1, possesses E3 ubiquitin
igase activity in addition to binding both DNA and
ultiple other proteins. Functionally, several lines of
vidence link the BRCA1 protein to HR (Scully et al.,
004). BRCA1 is a phosphorylation target of ATM and
he related PIKK, ATR, following DNA damage induc-
ion. BRCA1 forms a complex with Rad51 and BRCA2
Dong et al., 2003) and can be detected with Rad51 in
phase foci thought to represent stalled replication
orks. BRCA1 foci also form in response to ionizing ra-
iation and on chromosomes during meiotic recombi-
ation. BRCA1 deficiency leads to impaired HR-medi-
ted repair of chromosomal DSBs, hypersensitivity to
any DNA-damaging agents, and genomic instability.
he biochemical nature of BRCA1’s involvement in HR
emains unclear; one possibility is that BRCA1 may per-
orm a scaffolding function, potentially coordinating the
ormation of functional repair complexes at DSBs. The
3 ubiquitin ligase activity of BRCA1 may also be rele-
ant in this context; BRCA1 may modify other proteins
uring HR to alter their functions or direct their degra-
ation. Additionally, BRCA1 has been implicated in
any other functions outside HR: transcription, G2/M
heckpoint control, chromatin remodeling, and X inacti-
ation (Scully et al., 2004). It has also been proposed
hat BRCA1 may play a role in NHEJ (Ting and Lee,
004). Thus, BRCA1 plays roles in numerous cellular
rocesses, including DNA repair.
RCA1 and Rad50 Hypomorphs
how Aging Phenotypes
efects in Rad50 or BRCA1 cause progeroid pheno-
ypes. Deficiency of Mre11, Nbs1, or Rad50 is not com-
atible with cellular survival (Stracker et al., 2004). How-
ver, homozygosity for a Rad50 hypomorphic allele
Rad50s/s) permits viability; Rad50s/s mice show a short-
ned life span, cancer predisposition, and hemato-
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al., 2002). Genomic instability is detectable in cells de-
rived from this animal. The attrition of the hema-
topoietic and male germ cell lineages occurs in large
measure due to p53-mediated signaling triggered by
genomic instability (Bender et al., 2002).
Homozyogous inactivation of BRCA1 results in early
embryonic lethality (Valerie and Povirk, 2003); however,
mice homozygous for a BRCA1 hypomorphic allele and
haploinsufficient for p53 (BRCA111/11/p53+/−) are via-
ble and have many features reminiscent of accelerated
aging: wasting, skin atrophy, osteopenia, and malig-
nancy (Cao et al., 2003b). There is compelling evidence
that this phenotype results from p53-dependent re-
sponses to unrepaired DNA damage (Cao et al., 2003b).
Baseline p53 protein levels are higher in BRCA111/11/
p53+/− mice than in p53+/− control animals. Similar to
some NHEJ-deficient MEFs, BRCA111/11 MEFs show
increased chromosomal abnormalities and premature
cellular senescence, and BRCA111/11 embryos show
tissue SA-β-galactosidase activity, a marker of senes-
cence. Thus, in both the Rad50s/s and BRCA111/11/
p53+/− mice, signs of premature aging occur as a con-
sequence of the p53-mediated responses to unrepaired
DNA damage. However, since BRCA1 and Rad50 are
both involved in multiple cellular processes, the possi-
bility exists that loss of other functions beyond theirFigure 4. HR at DSBs
See text for details. Reproduced by permission with modification from Oncogene (Valerie and Povirk, 2003), copyright 2003 Macmillan
Publishers Ltd.DNA repair roles may contribute to these aging-like mu-
tant phenotypes.
Single-Stranded DNA Lesions and Aging
Nucleotide Excision Repair
DNA lesions that affect only one DNA strand are re-
paired via BER or NER and its subpathways. Although
BER is thought to play a critical role in the repair of
oxidative lesions, mutations in genes involved in this
pathway do not produce aging manifestations: they are
either lethal or confer no obvious phenotypes (Hasty et
al., 2003). By contrast, lesions in some factors involved
in NER can lead to premature aging syndromes in mice
and humans. NER is activated by a wide range of helix-
distorting DNA lesions, including UV-induced photopro-
ducts, bulky chemical adducts, and certain oxidative
lesions. NER can be subdivided into two pathways,
global genome NER (GG-NER) and transcription-cou-
pled NER (TC-NER), which differ with respect to the
lesion detected and some of the factors involved
(Mitchell et al., 2003; Figure 5).
The basic NER machinery consists of the proteins
XPA through XPG, the CSA and CSB proteins, and
other participants such as the basal transcription factor
TFIIH. The GG-NER specific factors, XPC (in a complex
with the HR23B protein) and XPE are responsible for
detecting helix-distorting lesions that occur throughout
Cell
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mCSB, are involved in repair specifically in transcribed
regions and, when RNA polymerase II stalls at a lesion, t
Acontribute to displacing the stalled polymerase to cre-
ate access for repair machinery. Following recogni- c
mtion of the damaged DNA, common NER factors are
recruited in both GG-NER and TC-NER. TFIIH, which d
pcontains two DNA helicases, XPB and XPD, unwinds
the DNA flanking the lesion. The single-strand DNA t
t(ssDNA) binding protein RPA binds to and stabilizes the
unwound DNA strands, and XPA aids in lesion recogni- C
ation. Two structure-specific endonucleases, XPG and
XPF (the latter in a complex with the protein ERCC1), i
then make single-strand incisions on either side of the
lesion to release an oligonucleotide. The resulting gap i
mis filled by template-dependent DNA polymerization fol-
lowed by ligation. l
lSeveral core NER factors have been implicated in
processes aside from NER. XPB and XPD are critical in m
dRNA polymerase II transcription; CSB associates with
RNA polymerases I and II; and XPF/ERCC1 has been g
dimplicated in repair of interstrand crosslinks, homology
directed repair, and processing of the 3# G strand over- X
vhang at telomeres.
Some NER Defects Lead to Premature s
mAging Phenotypes
Numerous human patients and mouse strains with de- p
cfects in different NER factors exist, and some have phe-
notypes reminiscent of premature aging (Mitchell et al.,
2003). Defects in the TC-NER-specific factors CSA or W
DCSB lead to Cockayne syndrome in humans, a severely
debilitating disorder with striking progeroid features. D
hCSA- and CSB-deficient mice show much milder phe-
notypes than their human counterparts (Mitchell et al., m
d2003). Patients with specific mutations in XPD suffer
from trichothiodystrophy (TTD), a disease character- n
sized by photosensitivity, brittle hair, skin defects, and
a shortened life span. These patients show defects in t
etranscription of hair- and skin-specific transcripts (and
perhaps other mRNAs) (Bergmann and Egly, 2001). In b
paddition, cells derived from TTD patients show NER de-
fects, suggesting that multiple functions of XPD are de- iFigure 5. Global-Genome NER and Tran-
scription-Coupled NER
Factors with aging-related mutant pheno-
types (XPD, CSA, CSB, ERCC1, and XPF) are
shown in red. See text and Table 1 for details.
Reprinted with modification from Mitchell et al.
(2003) with permission from Elsevier.ective in these individuals. Mice bearing a targeted
utation in XPD that recapitulates a human TTD muta-
ion show similar manifestations to human TTD patients.
dditionally, these XPDTTD mice show aging-associated
hanges such as wasting, scoliosis, osteoporosis, and
elanocyte loss (de Boer et al., 2002). XPDTTD/XPA
ouble mutants show a much more rapid degenerative
henotype, suggesting that in the setting of impaired
ranscription and/or TC-NER, a total lack of NER is ex-
remely deleterious. Similarly, mice deficient in both
SB and XPA also die within a few weeks after birth,
lthough only cerebellar defects have been described
n detail in these animals (Murai et al., 2001).
The aging-like phenotypes in human CS patients and
n XPDTTD, XPDTTD/XPA, and CSB/XPA mouse mutants
ay be explained by the fact that a failure to repair
esions in transcribed genes can result in cell death,
eading to tissue attrition and aging. Stalled RNA poly-
erase provides a signal for activation of p53-depen-
ent apoptosis (Ljungman and Lane, 2004). In this re-
ard, it will be of interest to determine whether p53
eficiency rescues the aging-like features of XPDTTD,
PDTTD/XPA, and CSB/XPA mice. Alternatively, the in-
olvement of XPD and the CSB proteins in transcription
uggests that impaired transcription of critical genes
ay play a role in causing these progeroid phenotypes,
erhaps interacting with the repair defects in a compli-
ated fashion.
RN and Aging
efects in proteins with less well-defined functions in
NA repair can lead to aging phenotypes as well. The
uman disease WS represents the best model for pre-
ature aging in humans (Goto, 1997). WS patients
evelop premature graying, cataract, loss of subcuta-
eous fat, skin atrophy, osteoporosis, diabetes, athero-
clerosis, and malignancies. WS cells senesce prema-
urely in culture. The gene defective in WS, WRN,
ncodes a helicase of the RecQ family (a group defined
y its similarity to E. coli RecQ helicase). WRN also
ossesses an exonuclease domain. WRN plays a role
n the maintenance of overall genomic stability, and
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(Bachrati and Hickson, 2003).
Recent experiments using mice bearing targeted mu-
tations in WRN provide evidence that, with respect to
aging, the most relevant sites of WRN function are the
telomeres. WRN-deficient mice do not recapitulate hu-
man WS (Bachrati and Hickson, 2003). Based on the
observations that human WS cells show telomeric in-
stability (Schulz et al., 1996; Tahara et al., 1997) and
that introduction of telomerase into WS fibroblasts can
rescue their premature senescence (Wyllie et al., 2000),
it was proposed that WRN-deficient mice may not de-
monstrate a strong phenotype due to the abundant
mouse telomere reserve (Lombard et al., 2000). This hy-
pothesis has been proven correct by the generation of
mice deficient in both WRN and Terc (Chang et al.,
2004; Du et al., 2004). In the WRN/Terc double deficient
animals, phenotypes reminiscent of human WS that are
not observed in either single mutant are present: os-
teopenia, diabetes, and sarcomas. Phenotypes ordinar-
ily seen in late-generation Terc-deficient animals also
occur earlier in the compound mutants and are associ-
ated with a greater degree of telomeric dysfunction.
Whether or not these phenotypes depend on p53 func-
tion is unknown; the premature senescence of human
WS fibroblasts is p53 dependent (Davis et al., 2003).
The latter observation suggests that cellular checkpoint
functions may be involved in producing the clinical fea-
tures of WS.
The exact role of WRN in telomere maintenance is
currently unclear. WRN can be detected at the telo-
meres in the absence of telomerase function in mam-
malian cells (Johnson et al., 2001; Opresko et al., 2004),
and Sgs1p, the S. cerevisiae WRN homolog, is required
for recombinational telomere maintenance in telom-
erase-deficient cells in yeast (Cohen and Sinclair, 2001;
Huang et al., 2001; Johnson et al., 2001). WRN also in-
teracts with the telomeric protein TRF2 and can unwind
and degrade telomeric D loop structures. These obser-
vations suggest that WRN may play a role in providing
telomeric access to other factors involved in telomere
maintenance (Machwe et al., 2004; Opresko et al., 2004;
Orren et al., 2002). Overall, the phenotype of the WRN/
Terc double knockout mouse argues that defective
telomere maintenance is an important factor in produc-
ing the premature aging-like aspects of WS in humans,
although it does not exclude a role for other functions
of WRN at nontelomeric sites.
Sir2: A Link between Metabolism, Genome
Stability, and Life Span
In the models discussed above, decreased genomic
stability is associated with shortened life span. The Sir2
family of proteins provides an example in which in-
creased genomic stability extends life span (Blander
and Guarente, 2004). In S. cerevisiae, the chromatin
regulatory factor Sir2 (silent information regulator-2)
functions as an NAD-dependent histone deacetylase
(Imai et al., 2000) to suppress recombination and turns
off transcription at multiple genomic loci (Blander and
Guarente, 2004). One metric of aging in yeast is the
number of divisions that a single mother cell un-
dergoes. The excision and replication of rDNA circlesis an important cause of mortality in yeast when life
span is measured in this fashion (Sinclair and Guarente,
1997). Loss of Sir2 increases rDNA recombination and
shortens life span; whereas an extra genomic copy of
Sir2, which increases rDNA stability, extends life span
(Kaeberlein et al., 1999).
It has been proposed that Sir2 activity ties the energy
status of the yeast cell to longevity (Blander and Guar-
ente, 2004; Lin et al., 2000). When nutrients are scarce,
yeast cells preferentially employ respiration rather than
fermentation to generate ATP (Lin et al., 2002). This
metabolic switch alters the metabolism of the cell,
increasing the NAD/NADH ratio and/or decreasing
levels of the Sir2 inhibitor nicotinamide, in turn activa-
ting Sir2 and increasing rDNA stability (reviewed in
Blander and Guarente, [2004]). Strikingly, overexpres-
sion or pharmacologic activation of Sir2 in worms and
flies also extends life span (Rogina and Helfand, 2004;
Tissenbaum and Guarente, 2001; Wood et al., 2004).
Sir2-driven increased longevity in C. elegans requires
the Daf-16 transcription factor (Tissenbaum and Guar-
ente, 2001). Daf-16 is a critical mediator in the insulin-
like signaling pathway, normally employed by worms to
arrest as extremely long-lived larvae under unfavorable
environmental conditions; certain mutations in this
pathway confer longevity upon adult worms. The mech-
anisms by which Sir2 extends life span in flies are cur-
rently unclear. Sir2 family members may play a general
role in mediating caloric restriction (Sohal and Wein-
druch, 1996), an intervention capable of extending life
span in many different organisms from yeast to mam-
mals (Cohen et al., 2004; Howitz et al., 2003; Lin et al.,
2000; Rogina and Helfand, 2004; Wood et al., 2004),
although in yeast the involvement of Sir2 in CR appears
to be strain specific (Kaeberlein et al., 2004).
In mammals, there are seven Sir2 family members,
designated SIRT1–SIRT7 (Frye, 2000); SIRT1 is the
most highly related to S. cerevisiae Sir2. The role of
SIRT1 in mammalian longevity has not yet been directly
tested, since on a pure strain background SIRT1-defi-
cient animals die very early as a consequence of
multiple developmental defects (Cheng et al., 2003;
McBurney et al., 2003). Unlike yeast Sir2, which has no
known targets aside from histones, SIRT1 possesses a
large and growing list of targets, some of which, includ-
ing p53 and forkhead transcription factors (mammalian
homologs of Daf-16), modulate cellular resistance to
oxidative and genotoxic stress (Blander and Guarente,
2004). Additionally, SIRT1, like Sir2, has recently been
shown to directly modify chromatin and silence tran-
scription (Vaquero et al., 2004). It is now important to
determine whether SIRT1, in addition to silencing tran-
scription, also suppresses recombination and genomic
instability via chromatin effects and if so, whether such
an activity could be involved in regulating aging in
mammals. SIRT1 conditional alleles may allow studies
of the role of this protein in aging.
The true mammalian functional ortholog of Sir2, if
one exists, might also be a different mammalian Sir2
family member (or members) than SIRT1. SIRT2 and
SIRT3 are unlikely to play this role, because these pro-
teins are cytoplasmic and mitochondrial, respectively,
rather than chromatin associated (Blander and Guar-
ente, 2004). Thus far, no information has been forth-
Cell
508coming regarding the functions of the four remaining c
cSIRTs, SIRT4–SIRT7, but these remain candidates for
fproteins that may regulate longevity through genome
sstabilization.
h
oConclusions
eThe hypothesis that nuclear DNA, a critically important
ucellular constituent that cannot be replaced, is an im-
portant target of age-related change is supported by
sevidence that nuclear DNA damage and mutations ac-
scumulate with age. While ROS are likely to be one im-
fportant source of this damage, there are numerous
Aother cellular and environmental sources of damage,
p
and the impact of such lesions may be enhanced by
c
age-related compromise of DNA repair. In the latter
d
context, most premature aging syndromes are caused
t
by mutations in genes encoding proteins involved in
i
DNA repair (Karanjawala and Lieber, 2004). Accumula- a
tion of mutations in critical genes may be one general a
mechanism by which compromised DNA repair could b
contribute to aging. In addition, p53-mediated senes- 2
cence and apoptosis, in response to DNA damage, also c
likely contribute to aging (Figure 6). Indeed, the fact that i
lesions in several disparate repair systems cause phe- h
notypes that are broadly similar to one another (Table 1) r
is consistent with the notion that the specific chemical o
nature of the accumulated DNA lesions may be less l
important than their ability to activate the common cel- s
lular checkpoint machinery. m
It remains unclear why only certain DNA repair mu- c
tants in particular pathways show progeroid pheno- m
types. In some cases, it may simply be that some mu- m
tants have not been scrutinized sufficiently to reveal s
such effects. However, genetic background effects al- m
most certainly play an important role in modifying the i
aging-like manifestations of DNA repair deficiencies.
Also, it must be remembered that many of the DNA re- c
pair genes and factors implicated in suppressing aging b
also play roles in cellular processes other than DNA re- m
pair, and therefore aging-like phenotypes might be en- a
hanced by impairment of other cellular functions in d
oconjunction with altered DNA repair. In addition, as dis-Figure 6. A Model for the Role of Unresolved
DNA Lesions in Aging
Unrepaired DNA lesions can activate the cell
cycle checkpoint machinery, leading to se-
nescence or apoptosis and subsequent cel-
lular attrition and tissue dysfunction. Some
types of unrepaired DNA damage—like DNA
DSBs—can trigger genomic instability, which
can in turn lead to further DNA damage. In
addition, unrepaired DNA damage can di-
rectly compromise cellular processes like
transcription, an effect that could also impair
tissue function. Such unrepaired DNA dam-
age will be frequent in DNA repair mutants
and lead to accelerated degenerative changes;
in wild-type organisms unrepaired damage is
infrequent, owing to efficient repair systems.ussed above, environmental factors including housing
onditions, infectious agents, diet, and many other in-
luences, also likely play a significant role in the expres-
ion of aging phenotypes in mouse models and, per-
aps, in humans as well. Thus, aging is likely the
utcome of a complex interplay between the genetic
ndowment of an organism and the stresses placed
pon it by its particular environment.
All mouse models that link DNA repair to aging pos-
ess defects in DNA repair and have shortened life
pans. It is important to bear in mind the potential pit-
alls of such models (Hasty and Vijg, 2004; Miller, 2004).
ging encompasses a wide spectrum of degenerative
rocesses, many of which are quite nonspecific, both
linically and pathologically (Harrison, 1994). Thus, it is
ifficult to arrive at a strict, experimentally useful defini-
ion of aging. Factors implicated in organismal decline
n genetic models might not play a role in the normal
ging processes. A related difficulty is that premature
ging models fail to recapitulate all aspects of aging
ut are instead “segmental progerias” (Hasty and Vijg,
004; Miller, 2004); that is, they reproduce in an ac-
elerated fashion some but not all aspects of aging as
t occurs in wild-type animals. In this regard, the myriad
istopathologic changes of normal aging (Table 2) cor-
espond poorly with the changes that occur in models
f premature aging (Table 1). Mammalian aging is not
ikely a single process but rather the decline of many
omatic functions, heavily influenced by the environ-
ent; this is a complex interplay that is extremely diffi-
ult to model accurately. For these reasons, genetic
odels of extended life span are likely to be more infor-
ative than models with reduced longevity with re-
pect to physiologically relevant causes of decline and
ortality; in such long-lived organisms, life span-limit-
ng factors must of necessity be counteracted.
There are many outstanding questions regarding the
onnection between DNA repair and aging that will
enefit from the application of emerging techniques in
olecular biology and genetics. In models of premature
ging, the most vulnerable system fails first, leading to
eath and precluding gain of insights from effects on
ther, potentially more relevant, organ systems. This
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or via conditional knockouts of relevant genes. The lat-
ter approach, for example, might allow an evaluation of
the roles of genes essential during embryogenesis in
the aging process. Such an approach also could permit
insights into the types of DNA lesions that are most
important in causing aging in different tissues by allow-
ing impairment of specific DNA repair pathways in de-
fined cell populations. For example, tissue-specific de-
letion of DNA damage-response/checkpoint genes in
DNA repair mutants showing evidence of premature
aging might allow the direct effects of these DNA
lesions to be distinguished from the cellular responses
to them. Further insights into the basic biology of DNA
repair proteins, particularly regarding the exact nature
of the DNA lesions that these repair systems respond
to and their roles in checkpoints, may also shed more
light on the role of various DNA lesions in contributing
to aging.
Eventually, the importance of DNA damage in aging
might be directly tested via the generation of experi-
mental organisms with enhanced efficiency of DNA
maintenance, which would be predicted to show re-
tarded aging. Although the plethora of different repair
systems makes this a challenging, if not impossible,
undertaking, the existence of Sir2, a regulator of ge-
nome stability and aging in yeast, offers encourage-
ment for those seeking similar global regulators of
genome maintenance and potentially DNA repair in
mammals.
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